These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28390185)

  • 1. The Non-Peptide Vasopressin V1b Receptor Antagonist, SSR149415, Ameliorates Spermatogenesis Function in a Mouse Model of Chronic Social Defeat Stress.
    Wang B; Zhou J; Zhuang YY; Wang LL; Pu JX; Huang YH; Xia F; Lv JX
    J Cell Biochem; 2017 Nov; 118(11):3891-3898. PubMed ID: 28390185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic social defeat on behavioral and neural correlates of sociality: Vasopressin, oxytocin and the vasopressinergic V1b receptor.
    Litvin Y; Murakami G; Pfaff DW
    Physiol Behav; 2011 Jun; 103(3-4):393-403. PubMed ID: 21397619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of Stress-Induced ACTH Secretion by Vasopressin and CRH: Additional Evidence.
    Ramos AT; Tufik S; Troncone LR
    Neuropsychobiology; 2016; 73(3):184-90. PubMed ID: 27221315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the lateral septum is involved in the antidepressant-like effects of the vasopressin V1b receptor antagonist, SSR149415.
    Stemmelin J; Lukovic L; Salome N; Griebel G
    Neuropsychopharmacology; 2005 Jan; 30(1):35-42. PubMed ID: 15367924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of the vasopressin V1b receptor antagonist SSR149415 in the Flinders Sensitive Line rat.
    Overstreet DH; Griebel G
    Pharmacol Biochem Behav; 2005 Sep; 82(1):223-7. PubMed ID: 16181667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
    Serradeil-Le Gal C; Wagnon J; Tonnerre B; Roux R; Garcia G; Griebel G; Aulombard A
    CNS Drug Rev; 2005; 11(1):53-68. PubMed ID: 15867952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.
    Breuer ME; van Gaalen MM; Wernet W; Claessens SE; Oosting RS; Behl B; Korte SM; Schoemaker H; Gross G; Olivier B; Groenink L
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):101-6. PubMed ID: 18668225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD.
    Ferrier L; Serradeil-Le Gal C; Schulte AM; Vasina V; Gaultier E; Schroedel S; Ursino MG; Chaumaz G; Pascal M; De Ponti F; Bueno L
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1298-307. PubMed ID: 20864658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. V1b Receptor Antagonist SSR149415 and Naltrexone Synergistically Decrease Excessive Alcohol Drinking in Male and Female Mice.
    Zhou Y; Rubinstein M; Low MJ; Kreek MJ
    Alcohol Clin Exp Res; 2018 Jan; 42(1):195-205. PubMed ID: 29105118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of vasopressin 3 receptors in chronic psychological stress-induced visceral hyperalgesia in rats.
    Bradesi S; Martinez V; Lao L; Larsson H; Mayer EA
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G302-9. PubMed ID: 19033533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vasopressin V1b receptor antagonist, SSR149415, on anxiety-like behavior and Lewis lung carcinoma metastasis in mice.
    Amikishieva AV; Ilnitskaya SI; Nikolin VP; Popova NA
    Exp Oncol; 2011 Sep; 33(3):126-9. PubMed ID: 21956463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
    Serradeil-Le Gal C; Wagnon J; Simiand J; Griebel G; Lacour C; Guillon G; Barberis C; Brossard G; Soubrié P; Nisato D; Pascal M; Pruss R; Scatton B; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1122-30. PubMed ID: 11861823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist.
    Griffante C; Green A; Curcuruto O; Haslam CP; Dickinson BA; Arban R
    Br J Pharmacol; 2005 Nov; 146(5):744-51. PubMed ID: 16158071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats.
    Shimazaki T; Iijima M; Chaki S
    Eur J Pharmacol; 2006 Aug; 543(1-3):63-7. PubMed ID: 16843459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential roles of amygdaloid nuclei in the anxiolytic- and antidepressant-like effects of the V1b receptor antagonist, SSR149415, in rats.
    Salomé N; Stemmelin J; Cohen C; Griebel G
    Psychopharmacology (Berl); 2006 Aug; 187(2):237-44. PubMed ID: 16779555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonism of V1b receptors promotes maternal motivation to retrieve pups in the MPOA and impairs pup-directed behavior during maternal defense in the mpBNST of lactating rats.
    Bayerl DS; Kaczmarek V; Jurek B; van den Burg EH; Neumann ID; Gaßner BM; Klampfl SM; Bosch OJ
    Horm Behav; 2016 Mar; 79():18-27. PubMed ID: 26747375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic stress impairs male spermatogenesis function and Nectin-3 protein expression in the testis.
    Li T; Yao J; Zhang Q; Li Q; Li J; Wang X; Li W; Chen A; Yan J
    Physiol Res; 2020 Apr; 69(2):297-306. PubMed ID: 32324042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.